1963 - Fellow of the American Association for the Advancement of Science (AAAS)
The scientist’s investigation covers issues in Virology, Immunology, Viral replication, Virus and Human leukocyte antigen. Mark A. Brockman interconnects Epitope and Genetics, Gene, Immune system in the investigation of issues within Virology. His studies examine the connections between Epitope and genetics, as well as such issues in CTL*, with regards to Reverse transcriptase.
His biological study deals with issues like Cytotoxic T cell, which deal with fields such as Cytokine secretion. His Viral replication research integrates issues from Mutation, Viremia and CD8. His Human leukocyte antigen research includes themes of Allele and Group-specific antigen.
Mark A. Brockman mostly deals with Virology, Immunology, Human leukocyte antigen, Viral replication and Immune system. His Virology research is multidisciplinary, relying on both Epitope, T cell and Cytotoxic T cell, CTL*. Mark A. Brockman has included themes like Molecular biology, Cytokine secretion and Avidity in his Cytotoxic T cell study.
His studies in Human leukocyte antigen integrate themes in fields like Cellular immunity, Downregulation and upregulation, CD8 and Allele. He focuses mostly in the field of Viral replication, narrowing it down to topics relating to Viremia and, in certain cases, Infectivity. Mark A. Brockman works mostly in the field of Immune system, limiting it down to topics relating to Antibody and, in certain cases, Bioinformatics and Flow cytometry.
Mark A. Brockman mainly investigates Virology, Viral pathogenesis, Downregulation and upregulation, Immunology and T cell. The concepts of his Virology study are interwoven with issues in Disease progression and Genetic diversity. His Downregulation and upregulation research incorporates themes from Infectivity, Human leukocyte antigen, CTL* and Allele.
His research integrates issues of Mutation and Mutagenesis in his study of CTL*. His research in Immune system and Neutralizing antibody are components of Immunology. His work investigates the relationship between T cell and topics such as CD8 that intersect with problems in Viremia and Interleukin-7 receptor.
His primary scientific interests are in Downregulation and upregulation, Virology, Immune system, Cart and Viral pathogenesis. The Downregulation and upregulation study combines topics in areas such as Infectivity and Human leukocyte antigen. His studies deal with areas such as Viral entry, Nonsynonymous substitution and Antibody as well as Human leukocyte antigen.
His Virology study combines topics from a wide range of disciplines, such as Genetic diversity, Phylogenetic diversity, Phylogenetic tree and Subgenomic mRNA, Genome. His Immune system study results in a more complete grasp of Immunology. His study in Immunology focuses on Interleukin-7 receptor in particular.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction.
Daniel E Kaufmann;Daniel G Kavanagh;Florencia Pereyra;Florencia Pereyra;John J Zaunders.
Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.
Arne Schneidewind;Mark A. Brockman;Mark A. Brockman;Ruifeng Yang;Rahma I. Adam.
Journal of Virology (2007)
Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A
Mark A. Brockman;Arne Schneidewind;Matthew Lahaie;Aaron Schmidt;Aaron Schmidt.
Journal of Virology (2007)
IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells.
Mark A. Brockman;Mark A. Brockman;Douglas S. Kwon;Douglas S. Kwon;Douglas S. Kwon;Daniel P. Tighe;David F. Pavlik.
HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphocyte Recognition.
Toshiyuki Miura;Mark A. Brockman;Arne Schneidewind;Michael Lobritz.
Journal of Virology (2009)
TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection
Huabiao Chen;Zaza M Ndhlovu;Zaza M Ndhlovu;Dongfang Liu;Lindsay C Porter.
Herpes simplex virus.
Travis J Taylor;Mark A Brockman;Elizabeth E McNamee;David M Knipe.
Frontiers in Bioscience (2002)
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins
Zabrina L. Brumme;Zabrina L. Brumme;Mina John;Jonathan M. Carlson;Chanson J. Brumme.
PLOS ONE (2009)
Structural and Functional Constraints Limit Options for Cytotoxic T-Lymphocyte Escape in the Immunodominant HLA-B27-Restricted Epitope in Human Immunodeficiency Virus Type 1 Capsid
Arne Schneidewind;Mark A. Brockman;Mark A. Brockman;John Sidney;Yaoyu E. Wang.
Journal of Virology (2008)
Responsiveness of HIV-specific CD4 T cells to PD-1 blockade
Filippos Porichis;Douglas S. Kwon;Douglas S. Kwon;Douglas S. Kwon;Jennifer Zupkosky;Daniel P. Tighe.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: